POLYSAN Scientific & Technological Pharmaceutical Company
POLYSAN Scientific & Technological Pharmaceutical Company
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old | Viral Enteric Infection | Recruiting | Not stated | 2025-07-15 | NCT07066540 | |
| REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis | Acid-Base Imbalance, Diabetes Complications, Ketosis, Nutritional and Metabolic Diseases, acidosis disorder, diabetes mellitus, diabetic ketoacidosis, endocrine system disorder, metabolic disease | Recruiting | Phase 2 / Phase 3 | 2025-06-24 | NCT06955416 | |
| Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2025-04-06 | NCT06735898 |